SocraTec R&D GmbH   Report issue

For profit Phase 1 Phase 3 Phase 4
Founded: Frankfurt Germany (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2009
NCT00889850
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

SocraTec R&D GmbH | SocraTec R&D GmbH Clinical Pharmacology Unit | SocraTec R&D GmbH, Clinical Pharmacology Unit